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INTRODUCING Wnt16 ATTENUATES THE SEVERITY OF OSTEOARTHRITIS
Wenxue Tong a, Kinglun Kingston Mak b, Ling Qin a
aPrince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China
bSchool of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong,
China
Introduction: Osteoarthritis (OA) is the most common form of arthritis character-
ized by the degeneration of articular cartilage, intra-articular inflammation, and
osteophytes formation. Notably, OA chondrocytes undergo cellular changes that
recall hypertrophy and ossification process of the growth plate chondrocytes dur-
ing endochondral ossification. This “replay” at incorrect time and incorrect loca-
tion leads to subchondral bone pathological process and ossification
(osteophytes formation). Therefore, logically, many genes, including HIF-2a,
Runx2 and Hedgehog pathway, regulate the developmental endochondral ossifica-
tion, may also affect the osteophytes formation in OA pathology. Wnt signaling
pathway, one of the crucial pathways, regulates chondrocyte differentiation dur-
ing embryonic development and after birth. Our preliminary data suggests that
Wnt16, the last member of Wnt family currently, regulates cartilage differentia-
tion during embryonic mouse endochondral ossification. We hypothesize that
Wnt16 attenuates OA progression by inhibiting chondrocytes hypertrophy and
osteophytes formation. Our study aims to investigate the function of Wnt16 in
OA pathology and its potential for OA therapy.
Methods: The function of Wnt16 during embryonic skeleton development was
examined by whole-mount alizarin red and alcian blue staining in the newborn
of the ColIIa-creWnt16flox/flox conditional knockout (cKO) and wild type (WT)
mice respectively. Male mice from these two groups at 2 months of age were un-
dergo OA model surgery, and Ad-Wnt16 or Ad-Wnt16-shRNA was intra-articular
injected after OA model surgery. Samples were collected at designed time points
(Week 2, 4, 6 and 8) for mCT and histological evaluation of the OA progression. The
mechanism exploration was mainly performed in vitro by Q-PCR and western blot-
ting to detect the gene expression under Ad-Wnt16 or Ad-Wnt16-shRNA stimula-
tion, and the results were confirmed by histological staining. Results were
expressed as mean  standard deviation. Statistical analysis was carried out using
two-way ANOVA with Sidaks multiple comparisons test. P values of less than 0.05
were considered statistically significant.
Results: Wnt16 knockout did not affect the embryonic skeleton development.
However, mCT and histological analysis showed the cKO mice developed much
severer OA compared to the WT mice. Moreover, intra-articular injection of Ad-
Wnt16 significantly inhibited the OA process. For the mechanism exploration, we
discovered that many cartilage markers, including ColIIa, aggrecan, SOX9 and
Has2, were significantly decreased by IL-1b while promoted by Wnt16. However,
parathyroid hormone (PTH) pathway, which can inhibit chondrocytes hypertrophy,
was significantly decreased by IL-1b when Wnt16 absence, and significantly pro-
moted by Ad-Wnt16 both showed by Q-PCR and western blotting, and confirmed
by histological detection.
Discussion: In our current study, we showed a cartilage protective function of
Wnt16 and a potential target for OA therapy. Most studies in this field have focused
on blocking molecules that cause cartilage destruction. However, we now demon-
strate new ways by applying the tools that nature itself uses to protect cartilage
from injury. The OA protective role of Wnt16 suggest it as a potential target for
OA therapy and future development of strategies to deliver Wnt16 to joints may
prevent severe and permanent disability in patients suffering from cartilage loss.
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Background: SDF-1a is an extracellular chemokine, also known as CXCL12a,
which binds to its cell surface receptor CXCR4. High expressions of CXCR4 and
SDF-1a are associated with Rheumatoid arthritis and Osteoarthritis. However
the role of SDF-1a in chondrogenic differentiation still unclear. We aimed to
investigate the effects of the SDF-1a/CXCR4 axis in activation of the Wnt/b-catenin pathway in the chondrogenic differentiation of MSCs and articular
chondrocytes.
Subjects and Methods: MSCs and articular chondrocytes were cultured from
mouse. MSC cells were identified by three lines of differentiation and flow cytom-
etry. Passaged MSCs and chondrocytes were pretreated with SDF-1a for 7 days and
then analyzed for expression of Sox9, ACAN, Col2 proteins and Alcian blue staining.
The cultures were maintained for 14 days and then analyzed for expression of
Runx2, MMP-13, Col10, ALP proteins and ALP staining. Western blotting were
used to assess the expression of b-catenin, p-b-catenin, GSK-3b, p-GSK-3b,
Runx2, MMP-13, Col10 and ALP when chondrocytes were treated with Dickkopf-
1, and/or SDF-1a for 24 h.
Results: Alcian blue staining of MSCs and articular chondrocytes revealed that SDF-
1a had a limited effect on early chondrogenesis, and the expression of Sox9, ACAN,
Col2 showed little change. SDF-1a increased the expression of Runx2, MMP-13,
Col10 and ALP in MSCs and primary chondrocytes, implying a role of SDF-1a in
chondrocyte hypertrophy. SDF-1a induced the phosphorylation of b-catenin and
inhibited the phosphorylation of GSK-3b. The increased expression of hypertrophy
markers was significantly attenuated by inhibitors of WNT signaling.
Discussion and Conclusion: SDF-1a promoted the hypertrophy of MSCs and primary
chondrocytes, by inhibiting the Wnt/b-catenin signaling. These results suggest that
SDF-1a may have a negative effect on articular cartilage and clarify its role in OA
progression.
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HDAC6 INHIBITION SUPPRESSES CHONDROSARCOMA MALIGNANT PROPERTIES
AND RESTORES PRIMARY CILIA EXPRESSION
Wei Xiang, Kai Xu, Fengjing Guo
Tongji Hospital, Tongji Medical College, Huazhong University of Science and
Technology, China
Background: Chondrosarcoma is the second common primary malignant bone tu-
mor and characterized by secreting cartilage-like matrix to extracellular environ-
ment. Primary cilia is a microtubule-based organelle and functions as “antenna” to
detect various stimulus in extracellular environment. Recently, primary cilia is
found to be absent in chondrosarcoma but the mechanical of deciliation remains
unclear. Histone deacetylases 6 (HDAC6), as a special enzyme to regulate proteins
acetylated modification, can deacetylate a-tubulin which is the main structure of
primary cilia. In this manuscript, we try to evaluate the role of HDAC6 in regulating
chondrosarcoma cell malignant properties and primary cilia expression.
Subjects and Methods: Immunohistochemical assay was used to detect the expres-
sion of HDAC6 and primary cilia related Hedgehog pathway proteins in chondrosar-
coma tissues. CCK8 cell viability test, transwell and vasculogenic mimic assays
were conducted to detect the influences of inhibiting HDAC6 by using inhibitor
Tubastatin A and small interfering RNA(siRNA). Immunofluorescence test was
used to detect primary cilia expression in different conditions. Western blot and
real-time PCR (RT-PCR) assays were used to test related proteins and gene
expressions.
Results: Abnormal expressions of HDAC6 and Hedgehog pathway related proteins
were found in chondrosarcoma. Inhibition of HDAC6 resulted in down-regulating
chondrosarcoma cells viability and proliferation capacities in concentration and
time dependent manners and could suppress chondrosarcoma cells invasion and
vasculogenic mimicry capacities. Primary cilia restoration was detected after
inhibiting HDAC6 by Tubastatin A and siRNA. With the increasing concentration
of Tubastatin A, HDAC6 and proliferation relevant protein Cyclin D1 expression
were decreased as well as primary cilia related IFT88 and acetylated a-tubulin
increased. Small interfering RNA could down-regulate endogenous HDAC6 but
IFT88 and acetylated a-tubulin expressed highly in HDAC6 interfering group. The
results of RT-PCR suggested that down-regulating HDAC6 could lead a low expres-
sion of primary cilia related Hedgehog pathway target genes GLI1 and PTCH1.
Discussion and Conclusion: HDAC6 is a special member of histone deacetylases
and mainly deacetylate a-tubulin structure which is crucial to restore cilia assem-
bly. Meanwhile, microtubule, as vital component of cytoskeleton, is indispensable
to regulate mitotic spindle and primary cilia transformation, to maintain cell
morphology and intercellular junction. HDAC6 can directly deacetylate microtu-
bule structure so that affecting chondrosarcoma malignant properties. In this
study, these results have confirmed that inhibition of HDAC6 can suppress chondro-
sarcoma cells malignant properties such as proliferation, invasion and vasculogenic
mimicry capacities, and can restore primary cilia assembly accompanied with
affecting related gene and protein expression. In conclusion, promoting primary
cilia restoration by targeting HDAC6 may be a potential therapeutic method for
chondrosarcoma.
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